| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "C"
Results 81 - 90 of 959 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| cancer cells J Sekhon, P Pereira, N Sabbaghian, A R Schievella and R Rozen Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines doi:10.1038/sj.bjc.6600459 Abstract | Full article | PDF |
||||||||
| cancer chemotherapy M de Graaf, E Boven, D Oosterhoff, I H van der Meulen-Muileman, G A Huls, W R Gerritsen, H J Haisma and H M Pinedo A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug doi:10.1038/sj.bjc.6600143 Abstract | Full article | PDF W E Hardman, M P Moyer and I L Cameron Consumption of an omega-3 fatty acids product, INCELL AAFA™, reduced side-effects of CPT-11 (irinotecan) in mice doi:10.1038/sj.bjc.6600175 Abstract | Full article | PDF C G Alexopoulos, M Vaslamatzis and G Hatzidimitriou Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours doi:10.1038/sj.bjc.6690652 Abstract | Full article | PDF D Screnci, M J McKeage, P Galettis, T W Hambley, B D Palmer and B C Baguley Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs doi:10.1054/bjoc.1999.1026 Abstract | Full article | PDF P H J Houba, E Boven, I H van der Meulen-Muileman, R G G Leenders, J W Scheeren, H M Pinedo and H J Haisma A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer doi:10.1054/bjoc.2000.1640 Abstract | Full article | PDF M J McKeage, T Hsu, D Screnci, G Haddad and B C Baguley Nucleolar damage correlates with neurotoxicity induced by different platinum drugs doi:10.1054/bjoc.2001.2024 Abstract | Full article | PDF |
||||||||
| cancer consultation D McConnell, P N Butow and M H N Tattersall Improving the letters we write: an exploration of doctor-doctor communication in cancer care doi:10.1038/sj.bjc.6690374 Abstract | Full article | PDF |
||||||||
| cancer diagnostics J Závada, Z Závadová, M Zat'ovi  ová, L Hyr l and I Kawaciuk
Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients doi:10.1038/sj.bjc.6601264 Abstract | Full article | PDF |
||||||||
| cancer gene therapy A Evrard, P Cuq, J Ciccolini, L Vian and J-P Cano Increased cytotoxicity and bystander effect of 5-fluorouracil and 5'-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase doi:10.1038/sj.bjc.6690589 Abstract | Full article | PDF P Cuq, C Rouquet, A Evrard, J Ciccolini, L Vian and J-P Cano Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase doi:10.1054/bjoc.2001.1833 Abstract | Full article | PDF J Vermeij, Z Zeinoun, B Neyns, E Teugels, C Bourgain and J De Grève Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector doi:10.1054/bjoc.2001.2082 Abstract | Full article | PDF |
||||||||
| cancer genes G M Yousef, A Scorilas, A Magklara, N Memari, R Ponzone, P Sismondi, N Biglia, M Abd Ellatif and E P Diamandis The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer doi:10.1038/sj.bjc.6600590 Abstract | Full article | PDF G M Yousef, C A Borgoño, A Scorilas, R Ponzone, N Biglia, L Iskander, M-E Polymeris, R Roagna, P Sismondi and E P Diamandis Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis doi:10.1038/sj.bjc.6600623 Abstract | Full article | PDF |
||||||||
| cancer genetics T Bjørge, A K Lie, E Hovig, R E Gislefoss, S Hansen, E Jellum, H Langseth, K Nustad, C G Tropé and A Dørum BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study advance online publication, 2004-10-12 00:00:00.000; doi:10.1038/sj.bjc.6602199 Abstract | Full article | PDF A H Pieterse, A M van Dulmen, M G E M Ausems, F A Beemer and J M Bensing Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences? advance online publication, 2005-04-19 00:00:00.000; doi:10.1038/sj.bjc.6602570 Abstract | Full article | PDF C Featherstone, A Colley, K Tucker, J Kirk and M B Barton Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence doi:10.1038/sj.bjc.6603432 Abstract | Full article | PDF H S Evans, C M Lewis, D Robinson, C M J Bell, H Møller and S V Hodgson Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England doi:10.1054/bjoc.2000.1603 Abstract | Full article | PDF |
||||||||
| cancer genetics services D Wonderling, P Hopwood, A Cull, F Douglas, M Watson, J Burn and K McPherson A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics doi:10.1054/bjoc.2001.1893 Abstract | Full article | PDF |
||||||||
| cancer genomics P H Rooney, A Boonsong, J A McKay, S Marsh, D A J Stevenson, G I Murray, S Curran, N E Haites, J Cassidy and H L McLeod Colorectal cancer genomics: evidence for multiple genotypes which influence survival doi:10.1054/bjoc.2001.2095 Abstract | Full article | PDF |
||||||||
| cancer immunotherapy A D Gritzapis, A Mamalaki, A Kretsovali, J Papamatheakis, M Belimezi, S A Perez, C N Baxevanis and M Papamichail Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells doi:10.1038/sj.bjc.6600888 Abstract | Full article | PDF J D Lickliter, J Cox, J McCarron, N R Martinez, C W Schmidt, H Lin, M Nieda and A J Nicol Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction doi:10.1038/sj.bjc.6603599 Abstract | Full article | PDF R Sotiriadou, S A Perez, A D Gritzapis, P A Sotiropoulou, H Echner, S Heinzel, A Mamalaki, G Pawelec, W Voelter, C N Baxevanis and M Papamichail Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope doi:10.1054/bjoc.2001.2089 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||